About ABclonal Technology Co., Ltd.
ABclonal Technology Co., Ltd., based in Wuhan, Hubei, is a biotechnology company specialising in high-specificity research reagents. Its name sums up its proposition: antibodies (AB) produced with advanced clonal technology to guarantee batch-to-batch consistency.
Its catalogue includes primary and recombinant antibodies, recombinant proteins, ELISA kits and next-generation sequencing (NGS) reagents, including library preparation. The company serves areas such as cancer, immunology, neuroscience, cell biology and epigenetics, and its products are cited in numerous international publications.
ABclonal maintains commercial presence outside China and supplies academic laboratories, biotech firms and pharmaceutical companies. For reagent distributors, it represents a Chinese antibody brand with global ambition and a catalogue oriented towards translational research.
Its catalogue includes primary and recombinant antibodies, recombinant proteins, ELISA kits and next-generation sequencing (NGS) reagents, including library preparation. The company serves areas such as cancer, immunology, neuroscience, cell biology and epigenetics, and its products are cited in numerous international publications.
ABclonal maintains commercial presence outside China and supplies academic laboratories, biotech firms and pharmaceutical companies. For reagent distributors, it represents a Chinese antibody brand with global ambition and a catalogue oriented towards translational research.